Delivery Order SPE2DB25D3306-SPE2DB25FUAVP

Award Date 2/12/25
Potential Completion Date 2/13/25
Potential Value $7.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,232.76 firm fixed-price contract is for the supply of Dupixent 300 mg/2 ml pen injectors. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to supply Dupixent 300 mg/2 ml pen injectors. The $3,304.72 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dupixent 300 mg/2 ml pen injectors, a specialty medication used for various medical conditions. The contract has a ceiling value of $3,700.54 and runs through November 6, 2024. The contract is a firm-fixed-price, delivery order type, with no set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Dupixent 300 mg/2 ml pen injectors. The contract, valued at $6,035.96, is a firm-fixed-price delivery order with a completion date of June 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of Dupixent 300 mg/2 ml pen injectors. The contract, valued at $3,441.69, was awarded by the Defense Logistics Agency (DLA) and has a completion date of December 19, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml pen injectors. The $66,553.78 firm fixed-price delivery order is not set aside for any specific business category. It is part of a larger Indefinite Delivery Contract valued at up to $999,999,999 through December 2025, which enables the DLA Troop Support Medical to procure a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors. The $17,227.20 fixed-price contract has a completion date of September 26, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the military and other defense agencies. The company holds several Indefinite Delivery Contracts (IDCs) with DLA and other agencies for...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract, valued at $18,347.07, is for the provision of Dupixent 300 mg/2 ml pen injectors to support military treatment programs and facilities. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,406.15 Firm Fixed Price Delivery Order contract covers the supply of Dupixent 300 mg/2 ml pen injectors, with a period of performance through September 18, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml pens. The delivery order has a firm fixed price of $5,711.17 and a completion date of October 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
  • SPE2DB25D3306
    Indefinite Delivery Contract
  • SPE2DB25D3306-SPE2DB25FUAVP
    Delivery Order

This is a federal contract award to AmerisourceBergen Drug Corp for the delivery of Dupixent 300 mg/2 ml pen injectors, valued at $7,849.28. The contract was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 13, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor on this award. The contract is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/14/25, 10:34 AM